Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Pharmaceutical Treatment of Monkeypox Virus: A Narrative Review and Bibliometric Analysis

Version 1 : Received: 21 October 2022 / Approved: 24 October 2022 / Online: 24 October 2022 (03:38:12 CEST)

How to cite: Shamim, M.A.; Satapathy, P.; Padhi, B.K.; Veeramachaneni, S.D.; Akhtar, N.; Pradhan, A.; Agrawal, A.; Dwivedi, P.; Mohanty, A.; Pradhan, K.B.; Kabir, R.; Rabaan, A.A.; Alotaibi, J.; Al Ismail, Z.A.; Alsoliabi, Z.A.; Fraij, A.A.; Sah, R.; Rodriguez-Morales, A.J. Pharmaceutical Treatment of Monkeypox Virus: A Narrative Review and Bibliometric Analysis. Preprints 2022, 2022100347. https://doi.org/10.20944/preprints202210.0347.v1 Shamim, M.A.; Satapathy, P.; Padhi, B.K.; Veeramachaneni, S.D.; Akhtar, N.; Pradhan, A.; Agrawal, A.; Dwivedi, P.; Mohanty, A.; Pradhan, K.B.; Kabir, R.; Rabaan, A.A.; Alotaibi, J.; Al Ismail, Z.A.; Alsoliabi, Z.A.; Fraij, A.A.; Sah, R.; Rodriguez-Morales, A.J. Pharmaceutical Treatment of Monkeypox Virus: A Narrative Review and Bibliometric Analysis. Preprints 2022, 2022100347. https://doi.org/10.20944/preprints202210.0347.v1

Abstract

Monkeypox virus infection is a recognized public health emergency. Little research has been done on treatment options for this disease. Until recently, there was not a single published work describing the usage of specific drugs in human patients with monkeypox virus infection. This paper gives the first bibliometric analysis of monkeypox treatment options based on data available on PubMed and Scopus. It also reviews the specific drugs used in the treatment of monkeypox. That includes data on Tecovirimat, Cidofovir, Brincidofovir, and Vaccinia Immune Globulin. Tecovirimat is a promising option in progressive disease in terms of efficacy and safety. However, Brincidofovir has been associated with discontinuation of treatment. Cidofovir is also not the preferred drug among physicians. Currently, Tecovirimat can be further used for the management of aggravating cases. More studies should be conducted on Tecovirimat to treat this condition, mainly through controlled trials.

Keywords

monkeypox virus; infection; treatment; antiviral; drug; management; public health emergency; tecovirimat; cidofovir; bibliometric analysis

Subject

Medicine and Pharmacology, Pharmacology and Toxicology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.